These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16690496)

  • 1. Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
    Sun X; Ueda M; Yamashita T; Nakamura M; Bergström J; Zeledon Ramirez ME; Okajima M; Misumi S; Shoji S; Motomiya Y; Ando Y
    Amyloid; 2006 Mar; 13(1):20-3. PubMed ID: 16690496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.
    Misumi Y; Ando Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Uchino M
    J Pathol; 2009 Dec; 219(4):481-90. PubMed ID: 19790249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.
    Matsunaga N; Anan I; Forsgren S; Nagai R; Rosenberg P; Horiuchi S; Ando Y; Suhr OB
    Acta Neuropathol; 2002 Nov; 104(5):441-7. PubMed ID: 12410391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.
    Beirão I; Moreira L; Porto G; Lobato L; Fonseca I; Cabrita A; Costa PM
    Nephron Clin Pract; 2008; 109(2):c95-9. PubMed ID: 18596378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel tool for diagnosis of amyloidosis].
    Obayashi K; Ando Y
    Rinsho Byori; 2008 Nov; 56(11):986-93. PubMed ID: 19086454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
    Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
    Susuki S; Ando Y; Sato T; Nishiyama M; Miyata M; Suico MA; Shuto T; Kai H
    Amyloid; 2008 Jun; 15(2):108-16. PubMed ID: 18484337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end product is implicated in amyloid-related kidney complications.
    Matsunaga N; Anan I; Rosenberg P; Nagai R; Lundström O; Horiuchi S; Ando Y; Suhr OB
    Scand J Clin Lab Invest; 2005; 65(4):263-71. PubMed ID: 16076681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
    Tasaki M; Ueda M; Obayashi K; Koike H; Kitagawa K; Ogi Y; Jono H; Su Y; Suenaga G; Oshima T; Misumi Y; Yoshida M; Yamashita T; Sobue G; Ando Y
    Int J Cardiol; 2013 Dec; 170(1):69-74. PubMed ID: 24182678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
    Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M
    Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
    Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
    Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
    Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
    Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.
    Mazzeo A; Toscano A; Stromillo ML; Battaglini M; Messina C; Federico A; Vita G; De Stefano N
    J Neurol Sci; 2006 Jul; 246(1-2):31-5. PubMed ID: 16530227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe amyloid deposition in mammary glands of familial amyloid polyneuropathy patients.
    Tokuda T; Takei Y; Takayama B; Hoshii Y; Ikeda S
    Amyloid; 2007 Sep; 14(3):249-53. PubMed ID: 17701472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
    Hou X; Aguilar MI; Small DH
    FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.